Here, we present two novel αv integrin binding decapeptides, inhibiting invasion of HT1080 and MDA MB-231 tumor cells as well as the pro-invasive activity of primary breast CAFs, reducing their α-SMA level and matrix contraction ability. The gene discussed is ACTA1; the disease is neoplasm.